Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Pamela M. Hartigan"'
Publikováno v:
Statistics in Biosciences. 13:402-430
Intermediate events play an important role in determining the risk of a medical condition over time and should thus be accounted for in survival analysis. Myocardial infarction (MI) is one such condition whose hazard also depends upon the possible oc
Autor:
Nathaniel R. Smilowitz, Evan P. Carey, Binita Shah, Pamela M. Hartigan, Mary E. Plomondon, David J. Maron, Thomas M. Maddox, John A. Spertus, G.B. John Mancini, Bernard R. Chaitman, William S. Weintraub, Steven P. Sedlis, William E. Boden
Publikováno v:
The American journal of cardiology. 180
Randomized clinical trials have not demonstrated a survival benefit with percutaneous coronary intervention in stable ischemic heart disease (SIHD). We evaluated the generalizability of the COURAGE (Clinical Outcomes Utilizing Revascularization and A
Autor:
G.B. John Mancini, William E. Boden, Koon K. Teo, John A. Spertus, Pamela M. Hartigan, Daniel S. Berman, David J. Maron, William S. Weintraub, William J. Kostuk
Publikováno v:
Journal of the American College of Cardiology. 73:2049-2058
Background The importance of glycosylated hemoglobin A1c (A1c) control as part of comprehensive risk factor management in patients with stable ischemic heart disease (SIHD) and diabetes mellitus (DM) is controversial. Objectives The purpose of this s
Autor:
William E. Boden, Helen Vlachos, Vera Bittner, Michael E. Farkouh, Pamela M. Hartigan, Flora S. Siami, G.B. John Mancini, Robert L. Frye, Maria M. Brooks, Valentin Fuster, Mandeep S. Sidhu, Bernard R. Chaitman
Publikováno v:
Journal of the American College of Cardiology. 73:400-411
Background The optimal coronary revascularization strategy in patients with stable ischemic heart disease (SIHD) who have type 2 diabetes (T2DM) and chronic kidney disease (CKD) remains unclear. Objectives This patient-level pooled analysis sought to
Autor:
Valentin Fuster, G.B. John Mancini, Maria M. Brooks, Lucas C. Godoy, Robert L. Frye, Vera Bittner, Flora S. Siami, Helen Vlachos, Pamela M. Hartigan, Michael E. Farkouh, William E. Boden, Bernard R. Chaitman
Publikováno v:
Journal of the American College of Cardiology. 76(19)
Elevated low-density lipoprotein cholesterol (LDL-C) is associated with increased cardiovascular events, especially in high-risk populations.This study sought to evaluate the influence of LDL-C on the incidence of cardiovascular events either followi
Autor:
Helen Vlachos, Bernard R. Chaitman, Gilles R. Dagenais, Pamela M. Hartigan, William E. Boden, Vera Bittner, Maria M. Brooks, Robert L. Frye, G.B. John Mancini
Publikováno v:
Atherosclerosis. 277:186-194
Background and aims The impact of treatment strategies on outcomes in patients with stable coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM) according to presenting angina has not been rigorously assessed. Methods We performed a patie
Autor:
David J. Maron, William E. Boden, William J. Kostuk, Pamela M. Hartigan, John A. Spertus, G.B. John Mancini, Koon K. Teo, William S. Weintraub, Steven P. Sedlis, Daniel S. Berman
Publikováno v:
Journal of the American College of Cardiology. 72(19)
Individual risk factor control improves survival in patients with stable ischemic heart disease (SIHD). It is uncertain if multiple risk factor control further extends survival.This study determined whether a greater number of risk factors at goal pr
Autor:
G.B. John Mancini, David J. Maron, Santosh K. Padala, William E. Boden, Gary V. Heller, Pamela M. Hartigan, Steven P. Sedlis, William S. Weintraub, John A. Spertus, Bernard R. Chaitman, Koon K. Teo, Mandeep S. Sidhu
Publikováno v:
The American Journal of Cardiology. 116:1509-1515
The impact of baseline exercise capacity on clinical outcomes in patients with stable ischemic heart disease randomized to an initial strategy of optimal medical therapy (OMT) with or without percutaneous coronary intervention (PCI) in the Clinical O
Autor:
Marcin Dada, Paul Chan, Koon K. Teo, Brahmajee K. Nallamothu, William J. Kostuk, Steven P. Sedlis, Pamela M. Hartigan, G.B. John Mancini, William S. Weintraub, Steven M. Bradley, Daniel S. Berman, David J. Maron, William E. Boden, John A. Spertus
Publikováno v:
The American Journal of Cardiology. 116:167-173
Establishing the validity of appropriate use criteria (AUC) for percutaneous coronary intervention (PCI) in the setting of stable ischemic heart disease can support their adoption for quality improvement. We conducted a post hoc analysis of 2,287 Cli
Autor:
Zugui Zhang, William J. Kostuk, William S. Weintraub, David J. Maron, John A. Spertus, G.B. John Mancini, Steven P. Sedlis, William E. Boden, Koon K. Teo, Philip G. Jones, Pamela M. Hartigan, Daniel S. Berman
Publikováno v:
Circulation. Cardiovascular quality and outcomes. 11(5)
Background: Percutaneous coronary intervention (PCI) is a therapy to reduce angina and improve quality of life in patients with stable ischemic heart disease. However, it is unclear whether the quality of life after PCI is more dependent on the PCI o